| Predicate |
Object |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0085
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-28 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 |
| filingDate |
2012-04-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2014-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
2014-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-101399056-B1 |
| titleOfInvention |
A pharmaceutical composition for preventing or treating neurological diseases comprising stem cell-derived micro-vesicle as an active ingredient |
| abstract |
The present invention relates to a pharmaceutical composition for preventing or treating neural disease comprising stem cell-derived micro-vesicle as an active ingredient. According to the present invention, the composition of the present invention provides a cell therapeutic agent free from ethical problems and immunogenicity problems, thereby providing a safer and more effective therapeutic effect as compared with the conventional method using stem cells directly. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20160042484-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20220166146-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101818560-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20190083932-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20190083933-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11439608-B2 |
| priorityDate |
2012-04-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |